Recent advances in understanding xenotransplantation: Implications for the clinic

Expert Review of Clinical Immunology

Volumn 11, Issue 12, 2015, Pages 1379-1390

  Cooper, David K C ^a   Bottino, Rita ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

genetically engineered pig; immunobiology; islets pig; organs pig; xenotransplantation

Indexed keywords

ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; BLOOD CLOTTING DISORDER; CLINICAL MEDICINE; CLINICAL TRIAL (TOPIC); CORNEA; CORNEA TRANSPLANTATION; GRAFT SURVIVAL; HUMAN; INFLAMMATION; NERVE CELL; NONHUMAN; ORGAN TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; PIG; PRIMATE; REVIEW; XENOTRANSPLANTATION; ANIMAL; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; PROCEDURES; T LYMPHOCYTE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CORNEAL TRANSPLANTATION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84947044809     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2015.1083861     Document Type: Review

References (102)

1. Hara H, Cooper DK. The immunology of corneal xenotransplantation: A review of the literature. Xenotransplantation 2010;17(5): 338-49
2. Hara H, Cooper DK. Xenotransplantation-The future of corneal transplantation? Cornea 2011;30(4):371-8
3. Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantation: The next medical revolution? Lancet 2012;379(9816): 672-83
4. van der Windt DJ, Bottino R, Kumar G, et al. Clinical islet xenotransplantation: how close are we? Diabetes 2012;61(12):3046-55
5. Cooper DK. The case for xenotransplantation. Clin Transplant 2015; 29(4):288-93
6. Taniguchi S, Cooper DK. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997;79(1): 13-19
7. Cooper DK. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) 2012;25(1):49-57
8. Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg 1964;160:384-410
9. Lambrigts D, Sachs DH, Cooper DK. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998;66(5):547-61
10. Cooper DK, Satyananda V, Ekser B, et al. Progress in pig-to-nonhuman primate transplantation models. (1998-2013): A comprehensive review of the literature. Xenotransplantation 2014;21(5):397-419
11. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003;299(5605):411-14
12. Kobayashi T, Cooper DK. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Subcell Biochem 1999;32:229-57
13. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005;11(1):29-31
14. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005;11(1):32-4
15. Inverardi L, Clissi B, Stolzer AL, et al. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 1997; 63(9):1318-30
16. Terpstra W, Leenen PJ, van den Bos C, et al. Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of Cl2MDP liposomes. Leukemia 1997;11(7):1049-54
17. Basker M, Alwayn IP, Buhler L, et al. Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons. Transplantation 2001;72(7):1278-85
18. Sasaki H, Xu XC, Smith DM, et al. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 1999;67(1):31-7
19. Maeda A, Kawamura T, Ueno T, et al. The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E. Transpl Immunol 2013;29(1-4):76-81
20. Esquivel EL, Maeda A, Eguchi H, et al. Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G. Transpl Immunol 2015;32(2): 109-15
21. McGregor CG, Ricci D, Miyagi N, et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012;93(7):686-92
22. Azimzadeh A, Kelishadi S, Ezzelarab MB, et al. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement-regulatory protein. Xenotransplantation 2015. [Epub ahead of print]
23. Mohiuddin MM, Corcoran PC, Singh AK, et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 2012;12(3):763-71
24. Mohiuddin MM, Singh AK, Corcoran PC, et al. Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. J Thorac Cardiovasc Surg 2014;148(3): 1106-13.discussion 13-4.
25. Mohiuddin MM, Singh AK, Corcoran PC, et al. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model. Xenotransplantation 2014;21(1):35-45
26. Mohiuddin MM, Singh AK, Corcoran PC, et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am J Transplant 2014;14(2):488-9
27. Higginbotham L, Mathews D, Breeden CA, et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. Xenotransplantation 2015;22:221-30
28. Iwase H, Ekser B, Satyananda V, et al. Pig-to-baboon heart transplantation-first experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 2015;22:211-20
29. Iwase H, Liu H, Wijkstrom M, et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date. Xenotransplantation 2015; Epub ahead of print
30. Satyananda V, Hara H, Ezzelarab MB, et al. New concepts of immune modulation in xenotransplantation. Transplantation 2013; 96(11):937-45
31. Cowan PJ, Cooper DK, d'Apice AJ. Kidney xenotransplantation. Kidney Int 2014;85(2): 265-75
32. Wilhite T, Ezzelarab C, Hara H, et al. The effect of Gal expression on pig cells on the human T-cell xenoresponse. Xenotransplantation 2012;19(1):56-63
33. Phelps CJ, Ball SF, Vaught TD, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009;16(6): 477-85
34. Hara H, Witt W, Crossley T, et al. Human dominant-negative class II transactivator transgenic pigs-effect on the human anti-pig T-cell immune response and immune status. Immunology 2013;140(1): 39-46
35. Iwase H, Satyananda V, Zhou H, et al. Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs. Transpl Immunol 2015;32:99-108
36. Bouhours D, Pourcel C, Bouhours JE. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J 1996;13(6):947-53
37. Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011; 18(1):1-5
38. Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013;20(1):27-35
39. Burlak C, Paris LL, Lutz AJ, et al. Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs. Am J Transplant 2014;14(8):1895-900
40. Estrada JL, Martens G, Li P, et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation 2015;22:194-202
41. Byrne GW, Du Z, Stalboerger P, et al. Cloning and expression of porcine beta1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation 2014;21(6):543-54
42. Cowan PJ, Robson SC, d'Apice AJ. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 2011;16(2):214-21
43. Houser SL, Kuwaki K, Knosalla C, et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004;11(5):416-25
44. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008;172(6):1471-81
45. Lin CC, Ezzelarab M, Shapiro R, et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010; 10(7):1556-68
46. Miwa Y, Yamamoto K, Onishi A, et al. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation 2010;17(1):26-37
47. Yazaki S, Iwamoto M, Onishi A, et al. Production of cloned pigs expressing human thrombomodulin in endothelial cells. Xenotransplantation 2012;19(2):82-91
48. Burdorf L, Stoddard T, Zhang T, et al. Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury. Am J Transplant 2014; 14(5):1084-95
49. Ezzelarab MB, Ekser B, Azimzadeh A, et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation 2015;22(1):32-47
50. Iwase H, Ekser B, Zhou H, et al. Further evidence for a sustained systemic inflammatory response in xenograft recipients (SIXR). Xenotransplantation 2015; Epub ahead of print
51. Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011; 9(Suppl 1):182-8
52. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 2010;10(2):273-85
53. Ekser B, Burlak C, Waldman JP, et al. Immunobiology of liver xenotransplantation. Expert Rev Clin Immunol 2012;8(7): 621-34
54. Yeh H, Machaidze Z, Wamala I, et al. Increased transfusion-free survival following auxiliary pig liver xenotransplantation. Xenotransplantation 2014;21(5):454-64
55. Harris DG, Quinn KJ, French BM, et al. Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood. Xenotransplantation 2015; 22(2):102-11
56. Cooper DK, Ekser B, Burlak C, et al. Clinical lung xenotransplantation-what donor genetic modifications may be necessary? Xenotransplantation 2012;19(3): 144-58
57. Nagaraju S, Bottino R, Wijkstrom M, et al. Islet xenotransplantation: what is the optimal age of the islet-source pig? Xenotransplantation 2015;22(1):7-19
58. Wijkstrom M, Bottino R, Iwase H, et al. Glucose metabolism in pigs expressing human genes under an insulin promoter. Xenotransplantation 2015;22(1):70-9
59. van der Windt DJ, Bottino R, Casu A, et al. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007;14(4):288-97
60. van der Windt DJ, Marigliano M, He J, et al. Early islet damage after direct exposure of pig islets to blood: has humoral immunity been underestimated? Cell Transplant 2012;21(8):1791-802
61. Bottino R, Wijkstrom M, van der Windt DJ, et al. Pig-to-monkey islet xenotransplantation using multi-transgenic pigs. Am J Transplant 2014;14(10):2275-87
62. Echeverri GJ, McGrath K, Bottino R, et al. Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant 2009;9(11):2485-96
63. Fujita M, McGrath KM, Bottino R, et al. Technique of endoscopic biopsy of islet allografts transplanted into the gastric submucosal space in pigs. Cell Transplant 2013;22(12):2335-44
64. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000;69(11):2296-304
65. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12(3):304-6
66. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006;12(3): 301-3
67. van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009;9(12): 2716-26
68. Thompson P, Badell IR, Lowe M, et al. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011;11(12): 2593-602
69. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011;11(5):947-57
70. Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010;90(10):1054-62
71. Cardona K, Milas Z, Strobert E, et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007;7(10):2260-8
72. Shin JS, Kim JM, Kim JS, et al. Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets. Am J Transplant 2015. [Epub ahead of print]
73. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci USA 2009;106(21):8659-64
74. Leveque X, Cozzi E, Naveilhan P, Neveu I. Intracerebral xenotransplantation: recent findings and perspectives for local immunosuppression. Curr Opin Organ Transplant 2011;16(2):190-4
75. Choi HJ, Kim MK, Lee HJ, et al. Efficacy of pig-to-rhesus lamellar corneal xenotransplantation. Invest Ophthalmol Vis Sci 2011;52(9):6643-50
76. Choi HJ, Lee JJ, Kim MK, et al. Cross-reactivity between decellularized porcine corneal lamellae for corneal xenobridging and subsequent corneal allotransplants. Xenotransplantation 2014; 21(2):115-23
77. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344(8934): 1402-4
78. Matsumoto S, Tan P, Baker J, et al. Clinical porcine islet xenotransplantation under comprehensive regulation. Transplant Proc 2014;46(6):1992-5
79. Wynyard S, Nathu D, Garkavenko O, et al. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014. [Epub ahead of print]
80. Zhang MC, Liu X, Jin Y, et al. Lamellar keratoplasty treatment of fungal corneal ulcers with acellular porcine corneal stroma. Am J Transplant 2015;15(4): 1068-75
81. Cooper DK, Novitzky D, Wicomb WN, et al. A review of studies relating to thyroid hormone therapy in brain-dead organ donors. Front Biosci (Landmark Ed) 2009;14:3750-70
82. Novitzky D, Mi Z, Sun Q, et al. Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis. Transplantation 2014;98(10):1119-27
83. Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 2010; 107(9):4305-10
84. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014;33(6):555-64
85. Cooper DK, Tseng YL, Saidman SL. Alloantibody and xenoantibody cross-reactivity in transplantation. Transplantation 2004;77(1):1-5
86. Atala A, Murphy S. Regenerative medicine. JAMA 2015;313(14):1413-14
87. Fox IJ, Daley GQ, Goldman SA, et al. Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science 2014; 345(6199):1247391
88. Kang L, Wang J, Zhang Y, et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009;5(2): 135-8
89. Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 2010;142(5): 787-99
90. Matsunari H, Nagashima H, Watanabe M, et al. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci USA 2013; 110(12):4557-62
91. Feng W, Dai Y, Mou L, et al. The Potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs. Int J Mol Sci 2015;16(3):6545-56
92. Onions D, Cooper DK, Alexander TJ, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000;7(2):143-55
93. Denner J. Infectious risk in xenotransplantation-what post-transplant screening for the human recipient? Xenotransplantation 2011;18(3):151-7
94. Soin B, Smith KG, Zaidi A, et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001;60(4): 1592-7
95. Ibrahim Z, Busch J, Awwad M, et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006;13(6):488-99
96. Ekser B, Echeverri GJ, Hassett AC, et al. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation 2010;90(5): 483-93
97. Tesson L, Usal C, Menoret S, et al. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 2011;29(8):695-6
98. Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods 2013;10(10):957-63
99. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014;157(6):1262-78
100. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346(6213):1258096
101. Ni W, Qiao J, Hu S, et al. Efficient gene knockout in goats using CRISPR/Cas9 system. PLoS One 2014;9(9):e106718
102. Li P, Estrada JL, Burlak C, et al. Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. Xenotransplantation 2015;22(1): 20-31